Skycrest Holdings LLC 13D and 13G filings for Organicell Regenerative Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:33 pm Unchanged |
2022-08-16 | 13D | Organicell Regenerative Medicine, Inc. BPSR |
Skycrest Holdings LLC | 200,000,000 12.300% |
0 (Unchanged) |
Filing |
| 2022-12-30 1:46 pm Purchase |
2022-08-16 | 13D | Organicell Regenerative Medicine, Inc. BPSR |
Skycrest Holdings LLC | 200,000,000 13.000% |
200,000,000 (New Position) |
Filing |